RGNX Price / Book | REGENXBIO Inc.

REGENXBIO Inc. (RGNX) Price / Book

2026-09-03: Price/Book Ratio 8.45.
2026-06-30: Price/Book Ratio 9.04.
2026-03-31: Price/Book Ratio 20.52.
2025-12-31: Price/Book Ratio 7.13.

Historical market capitalization divided by filed shareholder equity.

Available history: 2015-09-30 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	8.45
2026-06-30	9.04
2026-03-31	20.52
2025-12-31	7.13
2025-09-30	3.03
2025-06-30	1.94
2025-03-31	1.31
2024-12-31	1.48
2024-09-30	1.72
2024-06-30	1.66
2024-03-31	2.65
2023-12-31	2.54
2023-09-30	1.99
2023-06-30	2.15
2023-03-31	1.77
2022-12-31	1.9
2022-09-30	2.03
2022-06-30	1.69
2022-03-31	2.07
2021-12-31	1.83
2021-09-30	3.88
2021-06-30	3.26
2021-03-31	2.61
2020-12-31	4.5
2020-09-30	2.48
2020-06-30	3.45
2020-03-31	2.87
2019-12-31	3.37
2019-09-30	2.8
2019-06-30	3.82
2019-03-31	4.31
2018-12-31	2.98
2018-09-30	5.46
2018-06-30	7.3
2018-03-31	3.18
2017-12-31	5.69
2017-09-30	5.27
2017-06-30	2.88
2017-03-31	2.74
2016-12-31	3.04
2016-09-30	2.06
2016-06-30	1.08
2016-03-31	1.36
2015-12-31	2.01
2015-09-30	2.61

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Entera Bio Ltd. (ENTX)		$0.485B
Tectonic Therapeutic, Inc. (TECX)	United States	$0.469B	-7.68
Autolus Therapeutics plc (AUTL)		$0.506B	-1.52
Eikon Therapeutics, Inc. (EIKN)	United States	$0.446B
Kyverna Therapeutics, Inc. (KYTX)	United States	$0.434B	-3.60
Editas Medicine, Inc. (EDIT)	United States	$0.424B	-4.29
Scribe Therapeutics, Inc. (SCTX)	United States	$0.410B
Prime Medicine, Inc. (PRME)	United States	$0.557B	-3.54
Zura Bio Ltd (ZURA)		$0.398B	-6.56
Surrozen, Inc./DE (SRZN)	United States	$0.395B